Comparing the Impact of Omega-3 and Brahmi on Brain Performance in Young People

Comparative Study of Omega 3 Fatty Acids and Bacopa Monnieri on Cognitive Performance in Young Adults

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090565

Enrollment

Registered

2025-07-09

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Omega 3 Fatty Acids: Participants will consume one soft-gel capsule daily containing 300 mg omega-3 fatty acids (EPA + DHA). Control Intervention1: Bacopa Monnieri: Participants will co

Eligibility

Inclusion criteria

Inclusion criteria: No history of neurological or psychiatric disorders. Willingness to adhere to the study protocol.

Exclusion criteria

Exclusion criteria: Current use of cognitive enhancers or similar supplements. Known allergies to omega-3 fatty acids or Bacopa monnieri. Presence of medical conditions contraindicating supplementation.

Design outcomes

Primary

Measure	Time frame
Cognitive performance, measured using the NIMHANS Neuropsychology Battery: Memory: Verbal & Visual Learning, & Memory. Mental Speed: Visuomotor coordination, Response speed. Attention: Sustained & Divided attention. Executive Functioning: Category, Design & Verbal fluency, Working Memory, Concept formation, Abstract Reasoning.Timepoint: Baseline & at end of intervention.	—

Secondary

Measure	Time frame
Personality traits, assessed using the Personality Inventory for DSM-5 - Short Form (PID-5-SF).Timepoint: Baseline & at end of intervention.	—

Countries

India

Contacts

Public ContactJuslin Jacob

Government Medical College, Akola

dr.reenagiri@rediffmail.com7972851835

Outcome results